Development and Biophysical Characterization of a Humanized FSH–Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra–High Concentration is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3R01DK113627-04S1
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
National Institutes of Health
Grant: 5R01AG074092-03
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
National Institutes of Health
Grant: 3P20GM121301-05S1
COBRE in Mesenchymal and Neural Regulation of Metabolic Networks - Metabolic Phenotyping Equipment
National Institutes of Health
Grant: 3R01AG071870-03S1
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females
National Institutes of Health
Grant: 5U01AG073148-04
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
National Institutes of Health
Grant: 5U19AG060917-04
FSH - an Aging Hormone?
Keywords